首页|期刊导航|陆军军医大学学报|脂质纳米颗粒作为重组蛋白疫苗佐剂通过增强Th1/Th17应答保护幽门螺杆菌感染

脂质纳米颗粒作为重组蛋白疫苗佐剂通过增强Th1/Th17应答保护幽门螺杆菌感染OA

Lipid nanoparticles as adjuvants for recombinant protein vaccine protect against Helicobacter pylori infection by enhancing Th1/Th17 responses

中文摘要英文摘要

目的 幽门螺杆菌(Helicobacter pylori,HP)感染在全球范围内普遍存在,是诱发多种胃部慢性炎症及肿瘤性疾病的危险因素.近年来,脂质纳米颗粒因其良好的递送能力和免疫调节潜力,在疫苗佐剂研究中显示出广阔应用前景.因此,本研究拟制备脂质纳米颗粒(lipid nanoparticle,LNP),并评价其作为幽门螺杆菌重组蛋白疫苗佐剂的免疫增强作用及其对幽门螺杆菌感染的保护效果.方法 使用微流控技术制备LNP,利用透射电镜观察LNP形态以及动态光散射仪表征其粒径、平均分散系数及Zeta电位.体外实验评价LNP对树突状细胞(bone marrow derived dendritic cells,BMDCs)的激活作用.将6~8周龄雌性BALB/c小鼠(体质量17~20 g)按简单随机抽样法分为(n=10):PBS组、UreB/NapA组和LNP-H+UreB/NapA组;在第0、14和28天肌肉注射免疫小鼠,ELISA检测末次免疫后14 d小鼠血清中特异性抗体滴度,ELISpot检测小鼠脾脏中IFN-γ和IL-17A的分泌情况;使用幽门螺杆菌对小鼠进行攻毒,构建感染模型,感染4周后,通过探针法Real-Time PCR检测小鼠胃组织中幽门螺杆菌的定植量,通过体外AGS黏附实验评价免疫后小鼠对幽门螺杆菌的黏附抑制能力.结果 制备的LNP形态均一,平均粒径为100~120 nm,平均分散系数为0.1~0.2.LNP可促进BMDCs对抗原的吞噬,并显著提高BMDCs表面共刺激分子CD40、CD80、CD86的表达水平(P<0.001),具有促进BMDCs成熟的潜力;LNP显著提高BMDCs培养上清中IL-6和IL-1β的表达量(P<0.000 1).LNP与UreB和NapA联用后,显著提升血清中特异性总IgG、IgG1及IgG2a的滴度(P<0.05),并促进脾淋巴细胞中特异性IFN-γ和IL-17A的分泌(P<0.05),提示LNP可增强特异性T细胞免疫应答;降低幽门螺杆菌在小鼠胃组织中的定植量,并显著减少其对胃黏膜上皮细胞的黏附.结论 LNP可作为幽门螺杆菌重组蛋白疫苗佐剂,能有效增强体液免疫与细胞免疫应答,对幽门螺杆菌感染具有一定的保护作用.

Objective Helicobacter pylori(Hp)infection is prevalent worldwide and represents a risk factor for various chronic inflammatory and neoplastic gastric diseases.In recent years,lipid nanoparticles(LNPs)have demonstrated broad application prospects in vaccine adjuvant research owing to their favorable delivery capacity and immunomodulatory potential.Preparation of LNPs and evaluation of their immunoenhancing effects as adjuvants for a Helicobacter pylori recombinant protein vaccine,as well as their protective efficacy against H.pylori infection.Methods LNPs were prepared using microfluidic technology,with morphology examined by transmission electron microscopy and particle size and polydispersity index characterized by dynamic light scattering.The activating effects of LNPs on bone marrow-derived dendritic cells(BMDCs)were evaluated in vitro.For in vivo experiments,female BALB/c mice(6 to 8 weeks old,weighing 17 to 20 g)were randomly divided into(n=10):PBS group,UreB/NapA group,and LNP-H+UreB/NapA group.Mice were immunized by intramuscular injection on days 0,14,and 28.Serum specific antibody titers were measured by ELISA at day 14 after the final immunization,and IFN-γ and IL-17A secretion in mouse spleens was detected by ELISpot.Mice were challenged with H.pylori to establish an infection model.At 4 weeks post-infection,H.pylori colonization in gastric tissue was quantified by probe-based real-time PCR,and adhesion inhibition ability of immunized mice against H.pylori was evaluated through in vitro AGS cell adhesion assay.Results The prepared LNPs exhibited uniform morphology,with mean particle size of 100 to 120 nm and polydispersity index of 0.1 to 0.2.LNPs promoted the phagocytosis of antigens by BMDCs and significantly increase the expression levels of costimulatory molecules CD80,CD86,and CD40 on BMDC surfaces(P<0.001),indicating potential to promote BMDC maturation.LNPs also significantly enhanced the secretions of IL-6 and IL-1β in the supernatants of BMDCs(P<0.0001).When combined with UreB and NapA,LNPs remarkably elevated the serum titers of specific total IgG,IgG1,and IgG2a(P<0.05),and promoted the secretions of specific IFN-γ and IL-17A by splenic lymphocytes(P<0.05),suggesting that LNPs strengthen specific T-cell immune responses.Furthermore,LNPs reduced the colonization of H.pylori in mouse gastric tissues and significantly inhibited the adhesion to gastric mucosal epithelial cells.Conclusion LNPs can serve as an effective adjuvant for H.pylori recombinant protein vaccines,effectively enhancing humoral and cellular immune responses and conferring protective effects against H.pylori infection.

朱吉;王亚兰;邓炎;余文康;江悦;张苗苗;李海波

陆军军医大学(第三军医大学)药学与检验医学系微生物与生化药学教研室,国家免疫生物制品工程技术研究中心,重庆陆军军医大学(第三军医大学)药学与检验医学系微生物与生化药学教研室,国家免疫生物制品工程技术研究中心,重庆陆军军医大学(第三军医大学)药学与检验医学系微生物与生化药学教研室,国家免疫生物制品工程技术研究中心,重庆陆军军医大学(第三军医大学)药学与检验医学系微生物与生化药学教研室,国家免疫生物制品工程技术研究中心,重庆陆军军医大学(第三军医大学)药学与检验医学系微生物与生化药学教研室,国家免疫生物制品工程技术研究中心,重庆内蒙古大学生命科学学院,内蒙古呼和浩特陆军军医大学(第三军医大学)药学与检验医学系微生物与生化药学教研室,国家免疫生物制品工程技术研究中心,重庆

医药卫生

幽门螺杆菌疫苗佐剂脂质纳米颗粒

Helicobacter pylorivaccine adjuvantlipid nanoparticle

《陆军军医大学学报》 2026 (8)

991-1002,12

国家自然科学基金面上项目(32270988)重庆市自然科学基金面上项目(CSTB2024NSCQ-MSX0981) Supported by the General Program of National Natural Science Foundation of China(32270988)and the General Project of Natural Science Foundation of Chongqing(CSTB2024NSCQ-MSX0981).

10.16016/j.2097-0927.202512118

评论